Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor

Objective. To assess histological changes of colonic mucosa in patients with clinically different types of irritable bowel syndrome (IBS) before and after the treatment with tetracyclic antidepressant and selective serotonin reuptake inhibitor. Methods. Adult patients (over 18 years) with confirmed...

Full description

Bibliographic Details
Main Authors: Nagieva S., Svintsitskyy A., Kuryk O., Korendovych I.
Format: Article
Language:Russian
Published: Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy 2015-12-01
Series:Морфологія
Subjects:
Online Access:http://www.morphology.dp.ua/_pub/MORPHO-2015-09-04/15nsazzs.pdf
id doaj-c3ee85ec5bec4f2c86791488b7128be6
record_format Article
spelling doaj-c3ee85ec5bec4f2c86791488b7128be62020-11-25T01:45:11ZrusMinistry of Health of Ukraine. Dnipropetrovsk Medical Academy Морфологія1997-96651997-96652015-12-01944956Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitorNagieva S.0Svintsitskyy A.1Kuryk O.2Korendovych I.3Bogomolets National Medical University, Kyiv, UkraineBogomolets National Medical University, Kyiv, UkraineMedical centre “Universal clinic Oberig”, Kyiv, Ukraine; State Scientific Institution “Scientific and Practical Center of Preventive and Clinical Medicine” of Public Administration, Kyiv, UkraineBogomolets National Medical University, Kyiv, UkraineObjective. To assess histological changes of colonic mucosa in patients with clinically different types of irritable bowel syndrome (IBS) before and after the treatment with tetracyclic antidepressant and selective serotonin reuptake inhibitor. Methods. Adult patients (over 18 years) with confirmed diagnosis of IBS were examined. Biopsy specimens were taken from colon during colonoscopy for the next histological examination. One expert gastrointestinal pathologist assessed all tissue samples. We patent semi quantitative assessment of the severity of cell infiltration of colonic mucosa, which could be assessed as inflammatory (neutrophils), immune (lymphocytes, plasma cells, macrophages), or allergic (eosinophils) response (0 to 3 degrees). All patients received treatment due to the clinical variant of IBS: 1) IBS-constipation – mirtazapinum 15 mg/night+lactulose 30ml/morning (+30ml/night if needed); 2) IBS-diarrhea – escitalopram 5mg/night+rifaximine 600mg/twice a day; 3) IBS-unspecified – mirtazapinum 15 mg/escitalopram 5mg/ night; 4) IBS-mixed – mirtazapinum 15 mg, lactulose 30ml/morning (+30ml/night if needed) / escitalopram 5mg/night+rifaximine 600mg/twice a day. Results. 107 patients were examined, 36 of them had constipation (I group), 35 – diarrhea (II group), 22- unspecified variant (III group) and 12 patients had mixed variant of IBS (IV group) due to Rome III criteria (2006). 1st degree of lymphocyte infiltration was detected in 100% IBS-constipation patients and in 58,3% IBS-mixed variant (p<0.01). 1st degree of macrophage infiltration was seen in all patients except IBS-diarrhea (p<0.05). 2nd degree of lymphocyte infiltration was detected in 82,1% IBS-diarrhea patients and in 66,7% IBS-unspecified variant (p<0.01). 2nd degree of macrophage infiltration was seen in all patients except IBS-constipation, but more often in IBS-diarrhea (p<0.001). After the treatment we revealed the reduction of the degree of inflammation in all four groups of patients (zero and 1st degree, p>0.05). No cases of 2nd or 3rd degree of colonic mucosa infiltration were found. Conclusion. After the treatment with tetracyclic antidepressant and selective serotonin reuptake inhibitor we found that the degree of inflammation of colonic mucosa was reduced or disappeared, due to the zero degree of infiltration according to our patented classification. Citation: Nagieva S, Svintsitskyy A, Kuryk O, Korendovych I. [Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective seroto-nin reuptake inhibitor]. Morphologia. 2015;9(4):49-56. Ukrainian. http://www.morphology.dp.ua/_pub/MORPHO-2015-09-04/15nsazzs.pdfirritable bowel syndromebiopsycolonic mucosainfiltrationinflammation
collection DOAJ
language Russian
format Article
sources DOAJ
author Nagieva S.
Svintsitskyy A.
Kuryk O.
Korendovych I.
spellingShingle Nagieva S.
Svintsitskyy A.
Kuryk O.
Korendovych I.
Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
Морфологія
irritable bowel syndrome
biopsy
colonic mucosa
infiltration
inflammation
author_facet Nagieva S.
Svintsitskyy A.
Kuryk O.
Korendovych I.
author_sort Nagieva S.
title Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
title_short Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
title_full Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
title_fullStr Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
title_full_unstemmed Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
title_sort morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective serotonin reuptake inhibitor
publisher Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy
series Морфологія
issn 1997-9665
1997-9665
publishDate 2015-12-01
description Objective. To assess histological changes of colonic mucosa in patients with clinically different types of irritable bowel syndrome (IBS) before and after the treatment with tetracyclic antidepressant and selective serotonin reuptake inhibitor. Methods. Adult patients (over 18 years) with confirmed diagnosis of IBS were examined. Biopsy specimens were taken from colon during colonoscopy for the next histological examination. One expert gastrointestinal pathologist assessed all tissue samples. We patent semi quantitative assessment of the severity of cell infiltration of colonic mucosa, which could be assessed as inflammatory (neutrophils), immune (lymphocytes, plasma cells, macrophages), or allergic (eosinophils) response (0 to 3 degrees). All patients received treatment due to the clinical variant of IBS: 1) IBS-constipation – mirtazapinum 15 mg/night+lactulose 30ml/morning (+30ml/night if needed); 2) IBS-diarrhea – escitalopram 5mg/night+rifaximine 600mg/twice a day; 3) IBS-unspecified – mirtazapinum 15 mg/escitalopram 5mg/ night; 4) IBS-mixed – mirtazapinum 15 mg, lactulose 30ml/morning (+30ml/night if needed) / escitalopram 5mg/night+rifaximine 600mg/twice a day. Results. 107 patients were examined, 36 of them had constipation (I group), 35 – diarrhea (II group), 22- unspecified variant (III group) and 12 patients had mixed variant of IBS (IV group) due to Rome III criteria (2006). 1st degree of lymphocyte infiltration was detected in 100% IBS-constipation patients and in 58,3% IBS-mixed variant (p<0.01). 1st degree of macrophage infiltration was seen in all patients except IBS-diarrhea (p<0.05). 2nd degree of lymphocyte infiltration was detected in 82,1% IBS-diarrhea patients and in 66,7% IBS-unspecified variant (p<0.01). 2nd degree of macrophage infiltration was seen in all patients except IBS-constipation, but more often in IBS-diarrhea (p<0.001). After the treatment we revealed the reduction of the degree of inflammation in all four groups of patients (zero and 1st degree, p>0.05). No cases of 2nd or 3rd degree of colonic mucosa infiltration were found. Conclusion. After the treatment with tetracyclic antidepressant and selective serotonin reuptake inhibitor we found that the degree of inflammation of colonic mucosa was reduced or disappeared, due to the zero degree of infiltration according to our patented classification. Citation: Nagieva S, Svintsitskyy A, Kuryk O, Korendovych I. [Morphological changes of intestinal mucosa in patients with different clinical variants of irritable bowel syndrome using tetracyclic antidepressants and selective seroto-nin reuptake inhibitor]. Morphologia. 2015;9(4):49-56. Ukrainian.
topic irritable bowel syndrome
biopsy
colonic mucosa
infiltration
inflammation
url http://www.morphology.dp.ua/_pub/MORPHO-2015-09-04/15nsazzs.pdf
work_keys_str_mv AT nagievas morphologicalchangesofintestinalmucosainpatientswithdifferentclinicalvariantsofirritablebowelsyndromeusingtetracyclicantidepressantsandselectiveserotoninreuptakeinhibitor
AT svintsitskyya morphologicalchangesofintestinalmucosainpatientswithdifferentclinicalvariantsofirritablebowelsyndromeusingtetracyclicantidepressantsandselectiveserotoninreuptakeinhibitor
AT kuryko morphologicalchangesofintestinalmucosainpatientswithdifferentclinicalvariantsofirritablebowelsyndromeusingtetracyclicantidepressantsandselectiveserotoninreuptakeinhibitor
AT korendovychi morphologicalchangesofintestinalmucosainpatientswithdifferentclinicalvariantsofirritablebowelsyndromeusingtetracyclicantidepressantsandselectiveserotoninreuptakeinhibitor
_version_ 1725024647079002112